We found 24 individual miRNAs that had significant predictive value to classify women with breast cancer, including miR-340-5p from HER2+ EVs with an AUC of 0.87 and miR-223-3p from CD24+ EVs with an AUC of 0.75. This evidence concerns the gene ERBB2 and breast cancer.